drugset / Trial / NCT01882296
Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects Secondary object : Evaluate Dose-response of S-pantoprazole and pantoprazole and compare each dose-response
Timeline
- Start
- —
- Primary completion
- 2013-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pantoprazole | Other / unclassified | 20 mg | Oral |
| Comparator | Pantoprazole | Other / unclassified | 40 mg | Oral |
| Subject | S-pantoprazole | Unknown | 10 mg | Oral |
| Subject | S-pantoprazole | Unknown | 20 mg | Oral |
| Subject | S-pantoprazole | Unknown | 40 mg | Oral |
Indications
No indication recorded.